H.R. 8828 · 117th Congress

FDA Ethics Act of 2022

Stage
In committee
Sponsor
Ann Kuster
Introduced
2022-09-14
Latest action
2022-09-15 · Referred to the Subcommittee on Health.

Summary

FDA Ethics Act of 2022

This bill establishes several requirements for entities that contract with the Food and Drug Administration (FDA) relating to conflicts of interest, including requiring contractors to disclose conflicts of interest on an ongoing basis and prohibiting the FDA from hiring consultants who simultaneously provide services to drug manufacturers or other entities that are regulated by the FDA.